The Need for Public Education: 'Surveillance and Risk Reduction Strategies' for Women at Risk for Carrying BRCA Gene Mutations

Journal of Obstetrics and Gynaecology Canada

Volumn 29, Issue 6, 2007, Pages 510-511

  Nisker, Jeff A ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

BRCA gene mutation; Ethnic related cancer; Hereditary breast; Ovarian cancer; Public education

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

AUTOSOMAL DOMINANT INHERITANCE; BREAST CANCER; CANADA; CANCER SUSCEPTIBILITY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC VARIABILITY; HEALTH CARE ACCESS; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; NOTE; OVARY CANCER; PATIENT EDUCATION; PENETRANCE; PUBLIC HEALTH MESSAGE; RISK REDUCTION; TUMOR SUPPRESSOR GENE; BREAST TUMOR; FEMALE; GENETICS; MUTATION; OVARY TUMOR; RISK ASSESSMENT;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; HUMANS; MUTATION; OVARIAN NEOPLASMS; PATIENT EDUCATION; RISK ASSESSMENT;

EID: 34548107705     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32475-6     Document Type: Note

References (15)

1. Horsman D., Wilson B.J., Avard A., Meschino W.S., Kim Sing C., Plante M., et al. Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation. J Obstet Gynaecol Can 2007, 29:45-60.
2. Narod S., Feunteun J., Lynch H., Watson P., Conway T., Lynch J., et al. Familial breast-ovarian cancer locus on chromosome 1q12-q23. Lancet 1991, 338(8759):82-83. Jul 13.
3. Narod S., Lynch H., Conway T., Watson P., Feunteun J., Lenoir G. Increasing incidence of breast cancer in family with BRCA1 mutation. Lancet 1993, 341(8852):1101-1102. Apr 24.
4. Narod S.A., Madlensky L., Bradley L., Cole D., Tonin P., Rosen B., et al. Hereditary and familial ovarian cancer in Southern Ontario. Cancer 1994, 74:2341-2346.
5. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266(5182):66-71.
6. Struewing J.P., Abeliovich D., Peretz T., Avishai N., Kaback M.M., Collins F.S., et al. The carrier frequency of the BRCA1 183delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals 1995, 11:198-200.
7. Tonin P., Serova O., Lenoir G., Lynch H., Durocher F., Simard J., et al. BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet 1995, 57(1):189. Jul.
8. Tonin P.N., Mes-Masson A-M., Futreal P.A., Morgan K., Mahon M., Foulkes W.D., et al. Founder BRCA1 and BRCA2 mutations in French-Canadian breast and ovarian cancer families. Am J Hum Genet 1998, 63:1341-1351.
9. Thorlacius S., Olafsdottir G., Tryggvadottir L., Neuhausen S., Jonasson J.G., Tavtigian S.V., et al. A single CRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996, 13:117-119.
10. Nisker J. She lived with the knowledge. Ars Medica 2004, 1(1):75-80.
11. Nisker J., Martin D., Bluhm R., Daar A. Theatre as a public engagement tool for health-policy development. Health Policy 2006, 78(2-3):258-271.
12. Carroll J.C., Brown J.B., Blaine S., Glendon G., Pugh P., Medved W. Genetic susceptibility to cancer. Family physicians' experience. Can Fam Physician 2003, 49:45-52.
13. Warner E., Carroll J.C., Heisey R.E., Goel V., Meschino W.S., Lickley H.L., et al. Educating women about breast cancer. Can Fam Physician 2003, 49:56-63.
14. Warner E., Foulkes W., Goodwin P., Meschino W., Blondal J., Paterson C., et al. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 1999, 91(14):1241-1247.
15. Mykitiuk R. Caveat emptor: direct-to-consumer supply and advertising of genetic testing. Clin Invest Med 2004, 27(1):23-32.